本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

RayzeBio, Inc.

62.49
0.0000
成交量:- -
成交额:1,733.29万
市值:37.44亿
市盈率:-7.13
高:62.49
开:62.49
低:62.49
收:62.49
52周最高:62.51
52周最低:17.95
股本:5,991.95万
流通股本:3,481.97万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-8.7663
每股收益(LYR):-19.8964
净资产收益率:--
总资产收益率:--
市净率:6.51
市盈率(LYR):-3.14

数据加载中...

2024/02/28

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/26

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/02/16

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/26

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/01

重要事件披露

Form 8-K - Current report
2023/09/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/20

重要事件披露

Form 8-K - Current report
2023/09/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/12

SEC问询函

Form CORRESP - Correspondence
2023/09/12

SEC问询函

Form CORRESP - Correspondence
2023/09/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]